Sonoma Pharma wins FDA 510(k) clearance expanding Microdacyn wound solution indicationsPUBT·Jun 30 at 08:01 AMSNOA+2.73%
Sonoma Pharmaceuticals Expands At-the-Market Equity Offering CapacityTip Ranks·Jun 18 at 05:41 PMSNOA+2.73%
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | SNOA Stock NewsStockTitan·Jun 16 at 07:15 AMSNOA+2.73%
Sonoma Pharmaceuticals shares are trading higher after the company entered an agreement with Dawson James Securities to sell 2,962,962 units at $1.35 per unit.benzinga_article·May 1 at 01:20 PMSNOA+2.73%
Sonoma Pharmaceuticals Prices $1.35 Unit Offering, Nets ~$3.5M Under Underwriting With Dawson JamesTradingView·Apr 30 at 04:03 PMSNOA+2.73%SBIO+3.26%
What's Going On With Sonoma Pharma Stock Monday?benzinga_article·Apr 27 at 08:54 AMSNOA+2.73%FBT+0.87%
Sonoma Pharma Prices $4 Mln Offering Of Shares And Warrantsnasdaq·Apr 27 at 05:10 AMSNOA+2.73%LABU+7.13%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Apr 24 at 07:05 AMSNOA+2.73%TVGN+13.13%
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering | SNOA Stock NewsStockTitan·Apr 24 at 12:21 AMSNOA+2.73%XBI+2.40%
